AIM2 and head and neck squamous cell carcinoma: However, there were no statistical significances in the correlation between AIM2 expression and overall survival time in the TCGA HNSCC cohorts who received radiotherapy regardless of survival status and GSE42743 OSCC patients who received radiotherapy and were recorded as alive in the follow-up (Fig. 1F).